Vienna-based Flinn.ai, a startup that automates and optimises compliance processes for medtech firms, has secured €6M in seed spherical funding. This brings the corporate’s complete raised capital to €10M inside the previous 18 months.
The spherical was led by Berlin-based early-stage enterprise agency Cherry Ventures, with continued assist from current traders Speedinvest and SquareOne Enterprise Capital.
Enterprise angels together with Matthias Weber, former President at Leica Biosystems, and Michael Reitermann, former CEO of Siemens Diagnostics additionally participated on this spherical.
Capital utilisation
The funds will assist Flinn.ai speed up its mission to empower creators of well being merchandise by enhancing their capability to construct and function high-quality merchandise with a tenfold enhance in effectivity.
The corporate additionally plans to develop its AI-driven modules additional for high quality administration and regulatory compliance.
Bastian Krapinger-Rüther, co-founder and CEO of Flinn.ai, says, “Our AI options provide large potential to considerably enhance the standard of current medical gadgets. With the assist of Cherry Ventures and our different traders, we will speed up our imaginative and prescient of constructing high-quality healthcare merchandise accessible to everybody.”
What does Flinn provide?
Based in 2022 by Bastian Krapinger-Rüther, Markus Müller and Hasib Samad, Flinn.ai goals to rework the medtech sector with its Software program-as-a-Service options. The corporate specialises in automating post-market surveillance and streamlining compliance processes to reinforce effectivity for medtech producers.
Flinn.ai appears to empower medical gadget producers to automate compliance, enabling them to launch and function high-quality merchandise with ten instances the effectivity whereas making certain 100 per cent compliance.
The corporate employs a customer-centric, experimentation-driven method to product growth.
Its first product options AI-assisted post-market surveillance automation, providing instruments for automated knowledge assortment, built-in compliance actions, environment friendly analysis, and MDR-compliant reporting.
Flinn.ai’s three key modules embrace Automated Security Database Surveillance, Clever Literature Analysis, and AI-Pushed Grievance Knowledge Dealing with, all designed to enhance productiveness and danger administration within the medtech business.
